{"entity":{"type":"insider","cik":"0002024096","url":"/insider/0002024096","json_url":"/insider/0002024096.json","name":"Otero Jose Manuel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2025-08-20","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Otero Jose Manuel","source":"filing","n_filings":8,"first_seen":"2025-08-20","last_seen":"2026-08-19"}],"transactions":[{"id":9298595,"accession":"0002024096-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002024096-26-000013","line_url":"/filing/0002024096-26-000013#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":4.9571,"price_display":"4.96","price_state":"stated","total_value":6464.0584,"total_display":"6,464.06","shares_owned_after":136178.0,"shares_owned_after_display":"136,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":6084072,"accession":"0002024096-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002024096-26-000011","line_url":"/filing/0002024096-26-000011#line-2","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4666.0,"shares_display":"4,666","price_per_share":4.48,"price_display":"4.48","price_state":"stated","total_value":20903.68,"total_display":"20,903.68","shares_owned_after":137482.0,"shares_owned_after_display":"137,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-01","scope":"insider"},{"id":5952472,"accession":"0002024096-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002024096-26-000009","line_url":"/filing/0002024096-26-000009#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1302.0,"shares_display":"1,302","price_per_share":5.074,"price_display":"5.07","price_state":"stated","total_value":6606.348,"total_display":"6,606.35","shares_owned_after":130088.0,"shares_owned_after_display":"130,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":5925428,"accession":"0002024096-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002024096-26-000005","line_url":"/filing/0002024096-26-000005#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3016.0,"shares_display":"3,016","price_per_share":6.3972,"price_display":"6.40","price_state":"stated","total_value":19293.9552,"total_display":"19,293.96","shares_owned_after":125460.0,"shares_owned_after_display":"125,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":9297054,"accession":"0002024096-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002024096-26-000004","line_url":"/filing/0002024096-26-000004#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":721.0,"shares_display":"721","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":6683.67,"total_display":"6,683.67","shares_owned_after":63476.0,"shares_owned_after_display":"63,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2026-02-20","scope":"insider"},{"id":4484848,"accession":"0002024096-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002024096-25-000003","line_url":"/filing/0002024096-25-000003#line-3","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Technical Officer)","officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2091.0,"shares_display":"2,091","price_per_share":8.935,"price_display":"8.94","price_state":"stated","total_value":18683.085,"total_display":"18,683.08","shares_owned_after":64221.0,"shares_owned_after_display":"64,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":4484845,"accession":"0002024096-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002024096-25-000003","line_url":"/filing/0002024096-25-000003#line-2","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Technical Officer)","officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24.0,"shares_display":"24","price_per_share":9.561,"price_display":"9.56","price_state":"stated","total_value":229.464,"total_display":"229.46","shares_owned_after":64197.0,"shares_owned_after_display":"64,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":5040277,"accession":"0001415889-25-022479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022479","line_url":"/filing/0001415889-25-022479#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Technical Officer)","officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2848.0,"shares_display":"2,848","price_per_share":4.668,"price_display":"4.67","price_state":"stated","total_value":13294.464,"total_display":"13,294.46","shares_owned_after":60372.0,"shares_owned_after_display":"60,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4286353,"accession":"0002024096-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002024096-25-000005","line_url":"/filing/0002024096-25-000005#line-1","is_derivative":false,"issuer_cik":"0001907108","issuer_name":"Lexeo Therapeutics, Inc.","issuer_ticker":"LXEO","issuer_name_source":null,"issuer_url":"/issuer/0001907108","owner_cik":"0002024096","owner_name":"Otero Jose Manuel","owner_url":"/insider/0002024096","role":"Officer (Chief Technical Officer)","officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":721.0,"shares_display":"721","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":6683.67,"total_display":"6,683.67","shares_owned_after":63476.0,"shares_owned_after_display":"63,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-11-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001907108","name":"Lexeo Therapeutics, Inc.","url":"/issuer/0001907108","role":"Officer (Chief Operating Officer)","n_filings":8,"first_seen":"2025-08-20","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002024096","retrieved_at":"2026-08-21T11:04:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}